← All Neximmune, INC filings

Neximmune, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
NEXI
Neximmune, INC
10-K: NexImmune's 2023 10-K Filing: Strategic Shift to AIM INJ Platform Amidst Financial Challenges
NexImmune's 2023 10-K filing reveals a strategic realignment towards its AIM INJ platform, pausing clinical trials due to resource constraints, and ongoing efforts to secure additional funding.